SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X, a Bitcoin-native meme coin launched via the Runes protocol, is trending as the community rallies around its fair distribution and potential to drive utility on the Bitcoin network.  Many see it as a cultural movement and are actively discussing its unique position compared to other meme coins like $DOGE.X. Some community members also highlight the accumulation of $DOG.X by a publicly listed company.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor is trending as retail investors rally behind the stock, with discussions focusing on a potential gamma squeeze and speculation around a new celebrity investor possibly joining the "OPENARMY". Community members are also excited about potential upcoming catalysts like a new CEO announcement and possible interest rate cuts, contributing to the bullish sentiment. Many are debating entry strategies and expressing strong conviction in $OPEN, drawing comparisons to previous meme stock surges.

Memecoin on Injective taken over by the community.

Nonja

$NONJA.X is trending due to positive sentiment surrounding its strong community, unique NFT collection, and potential for high returns as a meme coin on the Injective protocol. Discussions highlight its strong liquidity, active community, and the belief that it will outperform the INJ token, especially with the anticipation of a possible Injective ETF and broader altcoin season.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

$SNAP is trending as traders buzz about potential AI integration and buyout rumors, with some pointing to activity on WallStreetBets and X as a potential catalyst. Community members are actively speculating on potential acquirers and comparing valuations to competitors like Reddit. Technical analysis and short squeeze potential are also being discussed.

Injective

Injective is trending as the community focuses on its relationship with meme coin $NONJA.X, highlighting its strong community, unique art, and burned liquidity pool; some believe $NONJA.X will outperform $INJ.X. Recent news of a staked $INJ.X ETF filing with the CBOE is also generating buzz, signaling potential institutional interest in the finance-focused L1 blockchain.

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

Seres Therapeutics is trending amid rumors of a potential acquisition by Nestle, sparking excitement and speculation within the investment community. Community members are actively discussing the possibility of a buyout offer and the potential impact on shareholder value, while also considering alternative scenarios such as partnerships and mergers. High short interest adds fuel to the discussions, with some anticipating a potential short squeeze if the rumors gain further traction.

McDonald's Corp. engages in the operation and franchising of restaurants. It operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. The firm's products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, McCafe beverages, and other beverages. The company was founded by Raymond Albert Kroc on April 15, 1955, and is headquartered in Oak Brook, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is trending amid discussions about value perceptions and competitive strategies, with analysts weighing in on the stock's potential. The community is actively debating the impact of new menu items like snack wraps and the McCrispy strips, as well as the company's digital initiatives. Broader conversations involve consumer spending habits, pricing strategies, and the fast-food sector's overall performance.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX is trending as investors discuss the company's recent completion of a share buyback program and authorization of a new one, signaling management's confidence and potentially establishing a price floor. Community members are actively analyzing technical indicators, discussing potential price targets, and speculating on the possibility of a buyout. Bullish sentiment is building around the long-term potential of BRIUMVI and upcoming catalysts, while some express frustration with the stock's recent performance.

SSgA Active Trust - Technology Select Sector SPDR ETF

Technology Select Sector SPDR Fund

The Technology Select Sector SPDR Fund ($XLK) is trending amid discussions of potential market corrections, tariff implications, and sector rotation. Community members are analyzing technical indicators like death crosses and relative strength, while also weighing the impact of upcoming earnings reports from major tech companies.  Talk of potential opportunities in oversold sectors like healthcare is also circulating.

IAMGOLD Corp. engages in the exploration, development and production of gold and mineral resource properties. It owns and operates the Westwood mine in Quebec and the Cote Gold project, a development project located in Ontario. The firm also operates the Rosebel mine in Suriname, the Essakane mine in Burkina Faso, the Saramacca project, an exploration project located in Suriname, the Boto project, an exploration project located in Senegal. The company was founded by William D. Pugliese, Mark I. Nathanson, and Larry E. Phillips on March 27, 1990 and is headquartered in Toronto, Canada.

Iamgold Corp.

Iamgold Corp. is trending as community members discuss its potential for growth amid rising gold prices and increasing global uncertainty, with some suggesting it's significantly undervalued. Investors are weighing the impact of the new Cote Gold mine and potential shifts in the company's financial performance, as well as geopolitical factors such as operations in Burkina Faso. The stock is also being compared to other gold mining stocks, with discussions around potential price targets and catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

These five biotech stocks, all belonging to nano-, small- or mid-cap categories, notched the highest jump in Stocktwits message volume in the week ended Feb. 14, 2025:GlycoMimetics Inc. (+550% jump in chatter)GlycoMimetics, a late-stage biotech firm developing glycobiology-based cancer therapies, saw a surge in retail interest after a minor amendment to its merger agreement with Crescent Biopharma. The update refined the financing structure but kept intact the exchange ratio and ownership split. Once the deal closes, Crescent security holders, including new investors, will own about 96.9% of the combined company. Shares are up roughly 16% year-to-date (YTD).GRAIL Inc. (+500% jump in chatter)Cancer detection firm GRAIL made waves after announcing a partnership with Quest Diagnostics (DGX) to distribute its Galleri multi-cancer early detection test. Analysts at Guggenheim viewed the move as a major step toward broader accessibility. The stock has soared over 208% YTD.ADMA Biologics Inc. (+400% jump in chatter)ADMA Biologics, a biopharma company focused on plasma-derived therapies, saw rising buzz ahead of its upcoming fourth-quarter (Q4) earnings. Last month, it issued a preliminary report projecting full-year 2024 revenue between $417 million and $425 million, with total cash holdings exceeding $100 million. Despite the strong forecast, shares remain down more than 8% YTD.Moleculin Biotech Inc. (+295% jump in chatter)Moleculin Biotech gained traction after the FDA provided guidance on its Phase 3 trial for Annamycin, a next-generation anthracycline designed to treat relapsed/refractory acute myeloid leukemia (AML) and soft tissue sarcoma lung metastases. With an adjusted trial size, the company expects its first unblinding in late 2025 and another in early 2026. Shares have climbed over 25% YTD.Exelixis Inc. (+200% jump in chatter)Exelixis, an oncology-focused biotech, saw a surge in discussions after reporting Q4 earnings that topped estimates, prompting analysts to raise their price targets. Citi highlighted continued strength in its Cabometyx franchise and pointed to Zanza as a potential blockbuster drug. Shares are up 4.35% YTD.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Hand holding test tube over stock data on computer monitor. | Image source: Getty Images

Top 5 Biotech Stocks That Got Most Retail Buzz Last Week

From merger updates to earnings surprises, these healthcare stocks saw the biggest spike in Stocktwits chatter.

Equity

From merger updates to earnings surprises, these healthcare stocks saw the biggest spike in Stocktwits chatter.


Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024

Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024 Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024 PR Newswire WALTHAM, Mass., Nov. 12, 2024...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, PFIE, GLYC on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, PFIE, GLYC on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, PFIE, GLYC on Behalf of Shareholders...

GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting

GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that data from multiple clinical trials studying uproleselan in patients with acute myeloid leukemia (AML) have been accepted for presentation at...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTR, PFIE, GLYC on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTR, PFIE, GLYC on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTR, PFIE, GLYC on Behalf of Shareholders...

INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. - GLYC

INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. - GLYC INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders...

GLYCOMIMETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of GlycoMimetics, Inc. - GLYC

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed merger of GlycoMimetics, Inc. (NasdaqGM: GLYC) and...

Integrated Media Technology Limited (<a class="mention" data-mention="$IMTE" data-symbol-id="IMTE" href="https://stocktwits.com/symbol/IMTE" target="_blank">$IMTE</a>)IMTE stock rose 5% pre-market on Wednesday, building on a 9.39% rise to close at $1.98 in the previous session.The uptick in share price comes after the company appointed Zhiyun Tan to its board of directors. Tan has over a decade of experience in business and tax advisory services. According to the tech company, Tan’s addition to the board will bolster its advisory capabilities.<figure class="image"><img style="aspect-ratio:1279/286;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_30_064506_eab9455f6b.png" alt="Screenshot 2024-10-30 064506.png" width="1279" height="286"><figcaption>IMTE's Sentiment and Message Volume on Oct 30 as of 6:45 a.m. ET | Source: Stocktwits</figcaption></figure>Stocktwits retail sentiment skyrocketed to ‘extremely bullish’ (97/100), its highest mark this year, as message volume hit a one-year peak at ‘extremely high’ (95/100).The stock has lost 23% of its value so far in 2024.GlycoMimetics Inc. (<a class="mention" data-mention="$GLYC" data-symbol-id="GLYC" href="https://stocktwits.com/symbol/GLYC" target="_blank">$GLYC</a>)GlycoMimetics shares fell 16% pre-market Wednesday, following a massive 191% surge in the prior trading session, after announcing its acquisition of Crescent BioPharma, an oncology therapeutics developer focused on solid tumors.The merger has received approval from the boards of both companies, though closing remains contingent on stockholder approval and other customary conditions, with finalization expected by Q2 2025.Upon completion, GlycoMimetics plans to adopt Crescent Biopharma as its new name, marking a significant pivot in its strategic focus.<figure class="image"><img style="aspect-ratio:1280/282;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_30_065931_7a6c00f4c3.png" alt="Screenshot 2024-10-30 065931.png" width="1280" height="282"><figcaption>GlycoMimetics' Sentiment and Message Volume on Oct 30 as of 6:59 a.m. ET | Source: Stocktwits</figcaption></figure> Retail sentiment on Stocktwits has peaked for a second time this year to ‘extremely bullish’ (97/100) with ‘extremely high’ (97/100) message volume.GlycoMimetics’ stock has dipped 85% so far this year.Alphabet Inc. (<a class="mention" data-mention="$GOOG" data-symbol-id="GOOG" href="https://stocktwits.com/symbol/GOOG" target="_blank">$GOOG</a>)Shares of Google-parent Alphabet rose nearly 7% pre-market Wednesday, following a 1.2% gain in the prior session, after reporting strong quarterly earnings post-market close.Alphabet posted revenue of $88.27 billion, surpassing analysts’ expectations of $86.39 billion, and earnings of $2.12 per share, topping Wall Street’s forecast of $1.84 per share.The earnings report highlighted a historic milestone for Google-owned YouTube, which generated $50 billion in revenue for the first time.<figure class="image"><img style="aspect-ratio:1277/282;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_30_071149_0e8d6e2f5c.png" alt="Screenshot 2024-10-30 071149.png" width="1277" height="282"><figcaption>Alphabet's Sentiment and Message Volume on Oct 30 as of 7:11 a.m. ET | Source: Stocktwits</figcaption></figure>Retail sentiment around the stock remains in the ‘extremely bullish’ (92/100) territory with an uptick in chatter to ‘extremely high’ (87/100) amid the earnings buzz.Google’s stock has gained 31% so far in 2024.For updates and corrections email newsroom@stocktwits.com.Read more: <a href="https://stocktwits.com/news-articles/markets/equity/glw-stock-makes-retail-more-bullish-after-q3-earnings/cJ2DsSpRJw">Corning Stock Boosts Retail Bullishness As Wall Street Analysts Raise Price Targets Post Q3 Earnings</a> &nbsp;

Google is among the top 3 most bullish stocks on Stocktwits today

Alphabet, Integrated Media, GlycoMimetic: 3 Stocks Making Retail Most Bullish Pre-Market Today

Retail sentiment is bullish on all three stocks, driven by Google's impressive financial performance, GlycoMimetics' announcement of a merger and potential rebranding, and IMTE's recent board strengthening.

Integrated Media, GlycoMimetic, Alphabet: 3 Stocks Making Retail Most Bullish Pre-Market Today

GlycoMimetics Inc. (<a class="mention" data-mention="$GLYC" data-symbol-id="GLYC" href="https://stocktwits.com/symbol/GLYC" target="_blank">$GLYC</a>)<figure class="image"><img style="aspect-ratio:1318/314;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/GLYC_sentiment_and_message_volume_Oct_29_2d5d960690.png" alt="GLYC sentiment and message volume Oct 29.png" width="1318" height="314"></figure>Shares of GlycoMimetics surged over 200% on Tuesday, making it the top gainer across U.S. markets and reaching a near two-year high. The biotech firm’s rally follows news of its <a href="https://stocktwits.com/news-articles/markets/equity/glyc-stock-surges-on-acquisition-deal/cJ2uwL4RJq">acquisition agreement</a> with Crescent Biopharma, backed by a $200 million investment commitment from investors including Fairmount, Venrock Healthcare Capital, and BVF Partners.&nbsp;The combined company will operate under the Crescent Biopharma name. Retail sentiment on Stocktwits skyrocketed, shifting to “extremely bullish” (97/100) from “neutral” on Monday.Canaan Inc. ($CAN)<figure class="image"><img style="aspect-ratio:1318/314;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/CAN_sentiment_and_message_volume_Oct_29_41df60828f.png" alt="CAN sentiment and message volume Oct 29.png" width="1318" height="314"></figure>Shares of Canaan Inc., a company focused on Bitcoin mining technology, surged nearly 20% to a three-month high on Tuesday as Bitcoin’s price reached a peak of $72,338 — its highest level since April.&nbsp;This Bitcoin surge fueled significant retail interest, causing Canaan’s Stocktwits sentiment score to jump to “extremely bullish” (97/100) from a previous “bearish” outlook.PayPal Holdings Inc. ($PYPL)<figure class="image"><img style="aspect-ratio:1318/314;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/PYPL_sentiment_and_message_volume_Oct_29_7f56a8c668.png" alt="PYPL sentiment and message volume Oct 29.png" width="1318" height="314"></figure>Despite a 3% dip following its <a href="https://stocktwits.com/news-articles/markets/equity/paypal-stock-plummets-mixed-earnings-retail-investors-bullish/cJ2un8iRJm?source_caller=ui&amp;shortlink=sefos10f&amp;pid=ds&amp;af_click_lookback=7d&amp;af_xp=custom">Q3 earnings</a> report on Tuesday, which missed revenue expectations, PayPal saw a wave of retail optimism. The earnings report did exceed profit expectations, and management’s optimistic outlook reassured many investors, lifting Stocktwits sentiment to ‘extremely bullish’ (96/100).&nbsp;The divergence between sentiment and price suggests retail investors are focusing on PayPal’s long-term potential over short-term volatility.For updates and corrections, email&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="mailto:newsroom@stocktwits.com">newsroom@stocktwits.com</a>Read next: <a href="https://stocktwits.com/news-articles/markets/equity/tmtg-core-civic-humana-stocks-poised-for-gains-with-trump-victory-retail-sentiment-mixed/cJ2urOCRJp">TMTG, CoreCivic, Humana Stocks Poised For Gains With Trump Victory: Retail Sentiment Mixed</a>

The most bullish stock during Tuesday's mid-day trading | Source: Pixabay

GlycoMimetics, Canaan, PayPal: 3 Stocks Retail Is Most Bullish On Today

Acquisition news, Bitcoin ripping higher and management’s confident commentary despite a post-earnings dip are fueling a lot of optimism 

Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.

GLYC
GlycoMimetics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GLYC News

GLYC GlycoMimetics Inc